Refine
Has Fulltext
- yes (80)
Is part of the Bibliography
- yes (80) (remove)
Year of publication
Document Type
- Journal article (68)
- Book article / Book chapter (6)
- Conference Proceeding (4)
- Review (2)
Keywords
- Toxikologie (68)
- DNA (6)
- DNA binding (5)
- Genotoxicity (5)
- Carcinogen (4)
- Carcinogenesis (3)
- Carcinogens (3)
- Ernährung (3)
- Medizin (3)
- Aflatoxin (2)
- Ames test (2)
- Benzene (2)
- DNA Binding (2)
- Dose response (2)
- Dose-response relationship (2)
- Estrogen (2)
- Hormone (2)
- binding (2)
- carcinogen (2)
- (Rat liver) (1)
- (Salmonella) (1)
- 1 (1)
- 2-Acetylaminofluorene (1)
- 2-Dichloroethane (1)
- 2-acetylaminofluorene (1)
- 4'-hydroxylation (1)
- 4-(p-nitrobenzyl)pyridine (1)
- 8-Hydroxy-deoxyguanosine (1)
- Aflatoxin B1 (1)
- Alkylation (1)
- Amino acid composition (1)
- Amino acids (1)
- Aminosäuren (1)
- Anabolieagent (1)
- Aniline derivatives (1)
- Anthraquinone glycosides (1)
- Aryl hydrocarbon rnonooxygenase (1)
- Benzo(a)pyrene-DNA binding (1)
- Cancer prevention (1)
- Carcinogen risk Individual susceptibili (1)
- Carcinogenic potency (1)
- Carcinogenicity (1)
- Carcinogenität (1)
- Chemical carcinogenesis (1)
- Choline deficiency (1)
- Chromosome aberration (1)
- Covalent DNA binding (1)
- Covalent binding (1)
- Covalent binding index (1)
- Covalent binding index - Diethylstilbestrol (1)
- Cytochrome b5 (1)
- DNA binching (1)
- DNA damage (1)
- DNA methylation (1)
- DNA-Binding (1)
- DNS-Bindung (1)
- Electrophiles (1)
- Emodin (1)
- Endogenous genotoxicity (1)
- Enzyme induction (1)
- Epoxide hydrolase (1)
- Estrone (1)
- Gastric carcinogenesis (1)
- Genetic instability (1)
- Glutathione Stransferase (1)
- Immunization (1)
- Inhalation (1)
- Krebs (1)
- Krebs <Medizin> (1)
- MammaJian mutagenicity test (1)
- Mechanism of action (1)
- Metabolic activation (1)
- Metabolism saturation (1)
- Micronucleus test (1)
- Mutagenicity assay (1)
- Mutagens (1)
- Mutation assay (1)
- N-methyl-N-nitrosourea (1)
- Nitrosation (1)
- Nitrosierung (1)
- Oxygen radical (1)
- Pointmutation (1)
- Protein binding (1)
- Protein coding (1)
- Quantitative risk assessment (1)
- Radicals (1)
- Rat (1)
- Rat Iiver microsomes (1)
- Rat liver peroxisome (1)
- Reactive intermediates (1)
- Riot control agents (1)
- Risikoanalyse (1)
- Risk estimation (1)
- Salmonella typhimurium (1)
- Salmonella/microsome assay (1)
- Sensitivity (1)
- Short-term Carcinogenicity Test (1)
- Short-term tests (1)
- Spontaneous tumours (1)
- Structureactivity relationship (1)
- Styrol (1)
- Thymidine glycol (1)
- Toluene (1)
- Transgenic mouse (1)
- Transgenie mice (1)
- Trenbolone (1)
- Tritiated Water (1)
- Zellteilung (1)
- adduct (1)
- aflatoxin (1)
- aflatoxin B1 (1)
- alkylation (1)
- allelic variant (1)
- amine (1)
- amino acid (1)
- covalent (1)
- covalent binding (1)
- cytochrome P450 2C9 (1)
- diet (1)
- dose (1)
- endogenous (1)
- ethanol (1)
- extrapolation (1)
- genotoxic (1)
- heterogeneous population (1)
- impact pharmacogenetics (1)
- in vivo (1)
- individual (1)
- liver microsomes (1)
- mutagen (1)
- natural (1)
- nitrosation (1)
- nitroso compound (1)
- o-Chlorobenzylidene malononitrile (1)
- risk (1)
- stomach (1)
- susceptibility (1)
- tolbutamide substrate (1)
- tumour (1)
- urea (1)
- warfarin polymorphisms (1)
Institute
- Institut für Pharmakologie und Toxikologie (80) (remove)
The detection Iimit of the lacl transgenic mouse mutagenicity assay lies, in practice, at approximately a 50-100% increase in mutant frequency in treated animals over controls. The sensitivity of this assay in detecting genotoxins can be markedly improved by subchronic rather than acute application of the test compound. The lac/ transgenic mouse mutagenicity assay was compared quantitatively to rodent carcinogenicity tests and to presently used in vivo mutagenicity assays. With the genotoxic carcinogens tested thus far, a rough correlation between mutagenic potency and carcinogenic potency was observed: on average, to obtain a doubling in lacl mutant frequency the mice bad to be treated with a total dose equal to 50 times the TD50 daily dose Ievel. This total dose could be administered eilher at a high dose rate within a few days or, preferably, at a low dose rate over several weeks. This analysis also indicated that a lacl experiment using a 250-day exposure period would give a detection Iimit approximately equal to that of a long-term carcinogenicity study. In comparison to the micronucleus test or the chromosome aberration assay, acute sturlies with the presently available lacl system offered no increase in sensitivity. However, subchronic lacl sturlies (3-4-month exposure) resulted in an increase in sensitivity over the established tests by 1-2 orders of magnitude (shown with 2-acetylaminofluorene, N-nitrosomethylamine, N-nitrosomethylurea and urethane). 1t is concluded that a positive result in the lacl test can be highly predictive of carcinogenicity butthat a negative result does not provide a large margin of safety.